news
The N439K mutation improves the interaction between SARS-CoV-2 Spike protein…
1 February 2021 | By Hannah Balfour (Drug Target Review)
The N439K mutation improves the interaction between SARS-CoV-2 Spike protein and the viral receptor ACE2 and eludes antibody-mediated immunity, say investigators.